During the last session, Cellectar Biosciences Inc (NASDAQ:CLRB)’s traded shares were 1.98 million, with the beta value of the company hitting 0.52. At the end
Cellectar Biosciences Inc (NASDAQ:CLRB)’s traded shares stood at 14.58 million during the last session, with the company’s beta value hitting 0.55. At the close of
In the last trading session, 8.86 million Cellectar Biosciences Inc (NASDAQ:CLRB) shares changed hands as the company’s beta touched 0.49. With the company’s per share
Cellectar Biosciences Inc (NASDAQ:CLRB) has a beta value of 0.52 and has seen 321.65 million shares traded in the recent trading session. The company, currently
In the last trading session, 1.14 million shares of the Cellectar Biosciences Inc (NASDAQ:CLRB) were traded, and its beta was 0.51. Most recently the company’s
Cellectar Biosciences Inc (NASDAQ:CLRB)’s traded shares stood at 0.34 million during the last session, with the company’s beta value hitting 0.51. At the close of
In the last trading session, 1.05 million Cellectar Biosciences Inc (NASDAQ:CLRB) shares changed hands as the company’s beta touched 0.52. With the company’s per share
Cellectar Biosciences Inc (NASDAQ:CLRB) has a beta value of 0.53 and has seen 0.65 million shares traded in the recent trading session. The company, currently
In the last trading session, 1.0 million shares of the Cellectar Biosciences Inc (NASDAQ:CLRB) were traded, and its beta was 0.51. Most recently the company’s
In last trading session, Cellectar Biosciences Inc (NASDAQ:CLRB) saw 0.51 million shares changing hands with its beta currently measuring 1.01. Company’s recent per share price
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne